José Hernández-Muñoz, RPh, MPH, MSc, PhD

U.S. Food and Drug Administration, Silver Spring, MD, USA

Poster(s):

• (B-105) Assessment of Utilization Patterns of New Molecular Entities Approved in 2022 using the Sentinel Distributed Database
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (C-247) Cannabis-Related Healthcare Encounters among Commercially Insured Adults Aged 18-64 Years Contributing Data to the US Food And Drug Administration’s Sentinel, 2017-2022
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (SLC-020) Characterization of Mothers in the Sentinel Distributed Database Mother-Infant Linkage Table
  Tuesday, August 26, 2025

  12:15 PM - 1:15 PM ET

• (A-205) Electronic Health Record (EHR) Enhanced Signal Detection Using Tree-Based Scan Statistic Methods
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-221) Self-Reported Use of Non-FDA Approved Cannabinoid Products among Hospitalized Patients in a Large US Hospital Network
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-200) Strengthening inferential studies in the U.S. FDA Sentinel initiative: Results from a methodological demonstration project
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (C-062) Utilization of hormonal contraceptives during the postpartum period in the FDA Sentinel System
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET